U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07283497) titled 'Itraconazole Therapy In Bronchiectasis With Airway Mold' on Dec. 01.
Brief Summary: The primary objective of this study is to evaluate the feasibility of itraconazole therapy in patients with bronchiectasis and airway mold. Feasibility will be assessed through recruitment success, treatment adherence, tolerability, and participant retention. The study will also explore the impact on respiratory symptoms and airway microbiome diversity.
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Bronchiectasis
Fungal Infection of Upper Respiratory Tract
Intervention:
DRUG: Itraconazole 200 mg
Subjects will receive oral itr...